Martínez COC

Language: Spanish
References: 29
Page: 163-173
PDF size: 388.71 Kb.

ABSTRACT

Imaging diagnosis of adrenal tumors is increasingly frequent. Characterization and differentiation of benign adenomas and malignant injures is very important, mainly in the patient with malignant or functioning disease. Computed tomography, magnetic resonance imaging and positron emission tomography/computed tomography allowed greater precision in characterizing and differentiating the adrenal masses in a non-invasive way. This review explained the physiological principles supporting these techniques, its advantages and restrictions. The main characteristics of the most frequent adrenal tumor images were described, in addition to submitting an algorithm for the use of these diagnostic means.

REFERENCES

1. Boland G W. Adrenal imaging: why, when, what, and how? Part 1. Why and when to image? Am J Roentgenol. 2010;195:W377-W81.

2. Aron D, Terzolo M, Cawood TJ. Adrenal incidentalomas. Best Pract Res Clin Endocrinol Metab. 2012;26(1):69-82.

3. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology. 2008;249(3):757-65.

4. Boland GW. Adrenal imaging: why, when, what, and how? Part 2: What technique? Am J Roentgenol. 2011;196:W1-W5.

5. Johnson PT, Horton KM, Fishman EK. Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. Radiographics. 2009;29:1319-31.

6. Lee MJ, Hahn PF, Papanicolau l. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology. 1991;179:415-8.

7. Korobkin M, Brodeur FJ, Yutzy GG, Francis JR, Quint LE, Dunnick NR, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. Am J Roentgenol. 1996;166:531-6.

8. Aron D, Terzolo M, Cawood TJ. Adrenal incidentalomas. Best Pract Res Clin Endocrinol Metab. 2012;26(1):69-82.

9. Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, et al. AME Position Statement on adrenal incidentaloma. European Journal of Endocrinology. 2011;164:851-70.

10. Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics. 2009;29(5):1333-51.

11. Taffel M, Haji-Momenian S, Nikolaidis P, Miller FH. Adrenal imaging: a comprehensive review. Radiol Clin North Am. 2012;50(2):219-43.

12. McDermott S, O'Connor OJ, Cronin CG, Blake MA. Radiological evaluation of adrenal incidentalomas: current methods and future prospects. Best Pract Res Clin Endocrinol Metab. 2012;26(1):21-33.

13. Goenka AH, Shah SN, Remer EM, Berber E. Adrenal imaging: a primer for oncosurgeons. J Surg Oncol. 2012;106(5):543-8.

14. Halefoglu AM, Altun I, Disli C, Ulusay SM, Ozel BD, Basak M. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases. J Comput Assist Tomogr. 2012 Jul;36(4):367-74

15. Siegelman ES. Adrenal MRI: techniques and clinical applications J Magn Reson Imaging. 2012 Aug;36(2):272-85.

16. Song J, Zhang C, Liu Q, Yu T, Jiang X, Xia Q, et al. Utility of chemical shift and diffusion-weighted imaging in characterization of hyperattenuating adrenal lesions at 3.0 T. Eur J Radiol. 2012;81(9):2137-43.

17. Nakamura S, Namimoto T, Morita K, Utsunomiya D, Oda S, Nakaura T, et al. Characterization of adrenal lesions using chemical shift MRI: comparison between 1.5 Tesla and two echo time pair selection at 3.0 Tesla MRI. J Magn Reson Imaging. 2012;35(1):95-102.

18. O’Brien A, Oyanedel R, Huete A, Cruz F, Menías Ch. Masas suprarrenales: evaluación por tomografía computada y resonancia magnética. Revista Chilena de Radiología. 2009;15(1):31-8.

19. Xu B, Gao J, Cui L, Wang H, Guan Z, Yao S, et al. Characterization of adrenal metastatic cancer using FDG PET/CT. Neoplasma. 2012;59(1):92-9.

20. Wong KK, Arabi M, Zerizer I, Al-Nahhas A, Rubello D, Gross MD. Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers. Nucl Med Commun. 2011;32(9):764-81.

21. Boland GW, Dwamena BA, Jagtiani Sangwaiya M, Goehler AG, Blake MA, Hahn PF, et al. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011;259(1):117-26.

22. Alencar GA, Fragoso MC, Yamaga LY, Lerario AM, Mendonca BB. (18)F-FDGPET/ CT imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased (18)F-FDG uptake. J Clin Endocrinol Metab. 2011;96(11):3300-1.

23. Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. J Clin Endocrinol Metab. 2012;97(1):100-9.

24. Yoon JK, Remer EM, Herts BR. Incidental pheochromocytoma mimicking adrenal adenoma because of rapid contrast enhancement loss. AM J Roentgenol. 2006;187:1309-11.

25. Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeny AT, Mueller PR, et al. Pheochromocytoma: an imaging chameleon. Radiographics. 2004;24:87-99.

26. Chen CC, Carrasquillo JA. Molecular imaging of adrenal neoplasms. J Surg Oncol. 2012;106(5):532-42.

27. Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB, et al. Adrenocortical carcinoma: the range of appearance on CT and MRI. Am J Roentgenol. 2011;196:W706-14.

28. Deandreis D, Leboulleux S, Caramella C, Schlumberger M, Baudin E. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011;2(6):354-62.

29. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. Adrenal Incidentaloma Guidelines. Endocr Pract. 2009;15(1):3-20.